In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment
- PMID: 6376543
- PMCID: PMC425200
- DOI: 10.1172/JCI111401
In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment
Abstract
Rabbit antithrombin III (AT), purified by heparin-agarose, was labeled with iodine-131 by either the glucose oxidase-lactoperoxidase or iodine monochloride techniques. When intravenously injected, the disappearance of the 131I-AT from plasma was characterized by rapid initial decreases, and three-exponential equations were required for best fit of the plasma disappearance curves. This rapid 131I-AT removal was not caused by denaturation, as shown by comparison with results obtained when 131I-AT was biologically screened (injected into a first rabbit, and then transferred 16 h later in whole plasma to a second for kinetic evaluation) before injection. Thus, the same rapid initial loss of plasma 131I-AT was observed with screened preparations, and the plasma fractional catabolic rates of 0.716 +/- 0.048 and 0.673 +/- 0.051 day-1 for unscreened and screened 131I-AT were not significantly different. These results support the hypothesis that a vascular-endothelial AT compartment is present in rabbit. The fractions of the total-body AT in the plasma, the vascular-endothelial and the extravascular compartments were 0.337 +/- 0.031, 0.178 +/- 0.056, and 0.485 +/- 0.069, respectively. Two three-compartment kinetic models are discussed. The first pictures AT as distributing independently between plasma and two other compartments, and the second sees AT as first passing to the vascular-endothelial compartment, and then directly into the extravascular compartment. The plasma 131I-AT kinetic data was consistent with both models, but the sizes of the vascular-endothelial compartments were best predicted by the second. If AT catabolism was assigned to the plasma, both models generally underpredicted the whole-body radioactivities, while assignment of breakdown to the extravascular compartment generally resulted in overpredictions. This suggests that AT catabolism occurs from both plasma and extravascular compartments.
Similar articles
-
Comparison of the behaviour in vivo of two molecular forms of antithrombin III.Biochem J. 1985 Feb 1;225(3):557-64. doi: 10.1042/bj2250557. Biochem J. 1985. PMID: 3977846 Free PMC article.
-
Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.J Lab Clin Med. 1995 Dec;126(6):521-9. J Lab Clin Med. 1995. PMID: 7490511
-
In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools.Blood. 1985 Jul;66(1):13-9. Blood. 1985. PMID: 4005426
-
Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state.J Lab Clin Med. 1992 Mar;119(3):221-30. J Lab Clin Med. 1992. PMID: 1541872
-
Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin in rabbits.Am J Physiol. 1997 May;272(5 Pt 1):E824-31. doi: 10.1152/ajpendo.1997.272.5.E824. Am J Physiol. 1997. PMID: 9176182
Cited by
-
Clearance of thrombin in vivo: significance of alternative pathways.Mol Cell Biochem. 1986 Aug;71(2):97-105. doi: 10.1007/BF00214768. Mol Cell Biochem. 1986. PMID: 3022120 Review.
-
Comparison of the behaviour in vivo of two molecular forms of antithrombin III.Biochem J. 1985 Feb 1;225(3):557-64. doi: 10.1042/bj2250557. Biochem J. 1985. PMID: 3977846 Free PMC article.
-
Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.J Clin Invest. 1985 Aug;76(2):826-36. doi: 10.1172/JCI112040. J Clin Invest. 1985. PMID: 3875633 Free PMC article.
-
Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.J Clin Invest. 2003 Apr;111(7):989-99. doi: 10.1172/JCI15809. J Clin Invest. 2003. PMID: 12671048 Free PMC article.
-
Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.J Cell Biol. 1990 Sep;111(3):1293-304. doi: 10.1083/jcb.111.3.1293. J Cell Biol. 1990. PMID: 2144002 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources